Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion type Assertion NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_head.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion description "[Deciphering how this pathway is regulated and how FASTKD2 initiates the apoptotic response will allow for the development of therapeutic agents for the treatment of androgen-independent prostate cancer or Tamoxifen-unresponsive Estrogen Receptor negative tumors as well as metastatic breast or prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_provenance.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion evidence source_evidence_literature NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_provenance.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion SIO_000772 25409762 NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_provenance.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion wasDerivedFrom befree-2016 NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_provenance.
- NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_assertion wasGeneratedBy ECO_0000203 NP1238611.RAfC3pc9lAW91IU_nkeGwgMc0OV-3ori4jCaMBg1l0JkQ130_provenance.